Table 1.
Projected burden of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatictis (NASH) by the year of 2030 in different countries and regions based on modelling studies
| NAFLD | Percentage increase by the year of 2030 (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Country or region | Year | Overall rate (%) | NAFLD | NASH | D. cirrhosis* | HCC* | Liver death | References |
| Australia | 2019 | 22 | 25 | 40 | 85 | 75 | 90 | [32] |
| Canada | 2019 | 21 | 20 | 35 | 97 | 80 | 107 | [33] |
| Hong Kong | 2019 | 22 | 11 | 20 | 66 | 67 | 74 | [34] |
| Saudi Arabia | 2017 | 26 | 48 | 96 | 273 | 199 | 295 | [31] |
| Singapore | 2019 | 26 | 20 | 36 | 108 | 78 | 113 | [34] |
| South Korea | 2019 | 21 | 6 | 21 | 87 | 79 | 92 | [34] |
| Switzerland | 2018 | 24 | 18 | 35 | 52 | 46 | 41 | [35] |
| Taiwan | 2019 | 22 | 8 | 24 | 108 | 84 | 106 | [34] |
| United Arab Emirates | 2017 | 25 | 46 | 87 | 241 | 178 | 27 | [31] |
| United States | 2015 | 34 | 21 | 63 | 168 | 137 | 178 | [30] |
*D. cirrhosis, Decompensated cirrhosis; HCC, hepatocellualr carcinoma